On February 27, 2019, the Canaud Lab received $20,000 from the CLOVES Syndrome Community for the creation of animal models to test PIK3CA inhibitors and to study PIK3CA related overgrowth physiopathology. We are thankful and ready to take action.

Learn more about the CLOVES Syndrome Community